The Braidwood decision maintains the status quo for many patients, keeping preventive services covered by Medicaid under the ...

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

The finding that basophil counts may have prognostic significance aligns with a growing body of research into basophils in ...